Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis

Unlike many pathogens that are overtly harmful to their hosts, Mycobacterium tuberculosis can persist for years within humans in a clinically latent state. Latency is often linked to hypoxic conditions within the host. Among M. tuberculosis genes induced by hypoxia is a putative transcription factor, Rv3133c/DosR. We performed targeted disruption of this locus followed by transcriptome analysis of wild‐type and mutant bacilli. Nearly all the genes powerfully regulated by hypoxia require Rv3133c/DosR for their induction. Computer analysis identified a consensus motif, a variant of which is located upstream of nearly all M. tuberculosis genes rapidly induced by hypoxia. Further, Rv3133c/DosR binds to the two copies of this motif upstream of the hypoxic response gene alpha‐crystallin. Mutations within the binding sites abolish both Rv3133c/DosR binding as well as hypoxic induction of a downstream reporter gene. Also, mutation experiments with Rv3133c/DosR confirmed sequence‐based predictions that the C‐terminus is responsible for DNA binding and that the aspartate at position 54 is essential for function. Together, these results demonstrate that Rv3133c/DosR is a transcription factor of the two‐component response regulator class, and that it is the primary mediator of a hypoxic signal within M. tuberculosis.

[1]  G. Diaz,et al.  Autolysis and Secondary Growth of Mycobacterium tuberculosis in Submerged Culture , 1967, Journal of bacteriology.

[2]  D. Mitchison.  Understanding the chemotherapy of tuberculosis—current problems , 1992 .

[3]  Gary K. Schoolnik,et al.  ideR, an Essential Gene in Mycobacterium tuberculosis: Role of IdeR in Iron-Dependent Gene Expression, Iron Metabolism, and Oxidative Stress Response , 2002, Infection and Immunity.

[4]  E. W. Rypka,et al.  Phenotypic changes in mycobacteria grown in oxygen-limited conditions. , 1986, Journal of medical microbiology.

[5]  G. Schoolnik,et al.  Role of the extracytoplasmic‐function σ Factor σH in Mycobacterium tuberculosis global gene expression , 2002 .

[6]  J. Betts,et al.  Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling , 2002, Molecular microbiology.

[7]  M. Tompa,et al.  Discovery of novel transcription factor binding sites by statistical overrepresentation. , 2002, Nucleic acids research.

[8]  D. Saini,et al.  Cloning, overexpression, purification, and matrix-assisted refolding of DevS (Rv 3132c) histidine protein kinase of Mycobacterium tuberculosis. , 2002, Protein expression and purification.

[9]  T. Parish,et al.  Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement. , 2000, Microbiology.

[10]  M. Rajandream,et al.  Regulation of hmp Gene Transcription inMycobacterium tuberculosis: Effects of Oxygen Limitation and Nitrosative and Oxidative Stress , 1999, Journal of bacteriology.

[11]  W. Bishai,et al.  Exposure to Antibiotics Induces Expression of theMycobacterium tuberculosis sigF Gene: Implications for Chemotherapy against Mycobacterial Persistors , 1999, Antimicrobial Agents and Chemotherapy.

[12]  [1] Whole genome DNA microarray expression analysis of biofilm development by Vibrio cholerae O1 El Tor , 2001 .

[13]  Yanmin Hu,et al.  Transcription of the Stationary-Phase-AssociatedhspX Gene of Mycobacterium tuberculosis Is Inversely Related to Synthesis of the 16-Kilodalton Protein , 1999, Journal of bacteriology.

[14]  S. Dhandayuthapani,et al.  Interactions of OxyR with the promoter region of the oxyR and ahpC genes from Mycobacterium leprae and Mycobacterium tuberculosis , 1997, Journal of bacteriology.

[15]  W. Mcdermott,et al.  MICROBIAL PERSISTENCE : II. CHARACTERISTICS OF THE STERILE STATE OF TUBERCLE BACILLI , 1966 .

[16]  P. Small,et al.  The evolving relation between humans and Mycobacterium tuberculosis. , 1998, The New England journal of medicine.

[17]  G. Schoolnik,et al.  The Mycobacterium tuberculosis ECF sigma factor σE: role in global gene expression and survival in macrophages † , 2001, Molecular microbiology.

[18]  R. M. Simpson,et al.  The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  L. McCue,et al.  Identification and Characterization of Mycobacterial Proteins Differentially Expressed under Standing and Shaking Culture Conditions, Including Rv2623 from a Novel Class of Putative ATP-Binding Proteins , 2001, Infection and Immunity.

[20]  D. Collins,et al.  Electroporation at elevated temperatures substantially improves transformation efficiency of slow-growing mycobacteria. , 1996, FEMS microbiology letters.

[21]  J. Yon,et al.  Precise gene fusion by PCR. , 1989, Nucleic acids research.

[22]  G. Comstock,et al.  Preventive treatment of untreated, nonactive tuberculosis in an Eskimo population. , 1972, Archives of environmental health.

[23]  W. Bishai,et al.  Conditional Sigma Factor Expression, Using the Inducible Acetamidase Promoter, Reveals that the Mycobacterium tuberculosis sigF Gene Modulates Expression of the 16-Kilodalton Alpha-Crystallin Homologue , 1999, Journal of bacteriology.

[24]  Robertson He.  The Persistence of Tuberculous Infections , 1933 .

[25]  P. Brown,et al.  Exploring the metabolic and genetic control of gene expression on a genomic scale. , 1997, Science.

[26]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[27]  V. Kapur,et al.  Characterization of a two-component system, devR-devS, of Mycobacterium tuberculosis. , 2000, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[28]  B. Gicquel,et al.  Generation of unmarked directed mutations in mycobacteria, using sucrose counter‐selectable suicide vectors , 1996, Molecular microbiology.

[29]  P. Gangadharam.  Mycobacterial dormancy. , 1995, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[30]  B. Barrell,et al.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.

[31]  G. Schoolnik,et al.  Role of the extracytoplasmic-function sigma factor sigma(H) in Mycobacterium tuberculosis global gene expression. , 2002, Molecular microbiology.

[32]  D E Snider,et al.  Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. , 1995, JAMA.

[33]  Roger Woodgate,et al.  The Bacillus subtilis DinR Binding Site: Redefinition of the Consensus Sequence , 1998, Journal of bacteriology.

[34]  N. Brown,et al.  Molecular Microbiology , 1998, NATO ASI Series.

[35]  V. Katoch,et al.  Understanding the phenomenon of persistence in mycobacterial infections. , 1997, Indian journal of leprosy.

[36]  J. S. Parkinson,et al.  Communication modules in bacterial signaling proteins. , 1992, Annual review of genetics.

[37]  Thomas M. Shinnick,et al.  Microarray Analysis of the Mycobacterium tuberculosis Transcriptional Response to the Acidic Conditions Found in Phagosomes , 2002, Journal of bacteriology.

[38]  Yukari C. Manabe,et al.  Latent Mycobacterium tuberculosis–persistence, patience, and winning by waiting , 2000, Nature Medicine.

[39]  Thomas Dick,et al.  Mycobacterium bovis BCG Response Regulator Essential for Hypoxic Dormancy , 2002, Journal of bacteriology.

[40]  L. Wayne,et al.  Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis , 1994, Antimicrobial Agents and Chemotherapy.

[41]  L. Wayne,et al.  An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence , 1996, Infection and immunity.

[42]  D. Sherman,et al.  Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha -crystallin. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[43]  C. Dye,et al.  Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. , 1999, JAMA.

[44]  Georges Canetti,et al.  Textbook of Physiology , 1955, The Yale Journal of Biology and Medicine.

[45]  J. Tyagi,et al.  Molecular analysis of the dormancy response in Mycobacterium smegmatis: expression analysis of genes encoding the DevR-DevS two-component system, Rv3134c and chaperone alpha-crystallin homologues. , 2002, FEMS microbiology letters.

[46]  C. Sohaskey,et al.  Nonreplicating persistence of mycobacterium tuberculosis. , 2001, Annual review of microbiology.

[47]  K. Moelling,et al.  Therapy of tuberculosis in mice by DNA vaccination , 1999, Nature.

[48]  W. Bishai,et al.  Mechanisms of latency in Mycobacterium tuberculosis. , 1998, Trends in microbiology.

[49]  P. Brown,et al.  Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[50]  R. Fleischmann,et al.  Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative σ factor, SigH , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[51]  P. Butcher,et al.  Protein synthesis is shutdown in dormant Mycobacterium tuberculosis and is reversed by oxygen or heat shock. , 1998, FEMS microbiology letters.

[52]  A M Dannenberg,et al.  Immunopathogenesis of pulmonary tuberculosis. , 1993, Hospital practice.

[53]  M. L. Cohn,et al.  The Viability and Virulence of Old Cultures of Tubercle Bacilli. Studies on Twelve-Year Broth Cultures Maintained at Incubator Temperature. , 1933 .

[54]  P. Brennan,et al.  Characterization of the major membrane protein of virulent Mycobacterium tuberculosis , 1992, Infection and immunity.

[55]  D. Mitchison.  The Garrod Lecture. Understanding the chemotherapy of tuberculosis--current problems. , 1992, The Journal of antimicrobial chemotherapy.

[56]  T. Dick,et al.  Oxygen Depletion-Induced Dormancy in Mycobacterium bovis BCG , 1999, Journal of bacteriology.

[57]  Gupta Ud,et al.  Understanding the phenomenon of persistence in mycobacterial infections. , 1997 .

[58]  Christopher Dye,et al.  Global Burden of Tuberculosis: Estimated Incidence, Prevalence, and Mortality by Country , 1999 .

[59]  D. Snider,et al.  Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies. , 2015, The American review of respiratory disease.

[60]  G. Mahairas,et al.  Disparate responses to oxidative stress in saprophytic and pathogenic mycobacteria. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[61]  Dirk Schnappinger,et al.  Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding α-crystallin , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[62]  G. Schoolnik,et al.  Genome-wide expression profiling of intracellular bacteria: The interaction of Mycobacterium tuberculosis with macrophages , 2002 .

[63]  G. Schoolnik,et al.  Construction and characterization of a partial Mycobacterium tuberculosis cDNA library of genes expressed at reduced oxygen tension. , 1998, Gene.

[64]  R. Lathigra,et al.  The 14,000-molecular-weight antigen of Mycobacterium tuberculosis is related to the alpha-crystallin family of low-molecular-weight heat shock proteins , 1992, Journal of bacteriology.

[65]  Norman L. Cressy.  The Tubercle Bacillus in the Pulmonary Lesion of Man , 1955, The Yale Journal of Biology and Medicine.

[66]  D. Crane,et al.  Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial alpha-crystallin homolog , 1996, Journal of bacteriology.